Beyond The Printed Page

  1. Did You Expect It Would Take This Long To Go Public? 7/19/2021

    Laura Niklason, M.D., Ph.D., cofounder and CEO of Humacyte, explains some of the science of her regenerative medicines company so to be public via a SPAC.

  2. Have You Heard Of Eric Dube? 6/17/2021

    A primer on what makes Eric Dube, Ph.D., CEO of Travere Therapeutics and upcoming feature in Life Science Leader, so inspirational.

  3. How We Have Changed For The Better Thanks To COVID-19 5/17/2021

    An interview with Mei Mei Hu, cofounder and CEO of Vaxxinity, provides an example of how COVID-19 and Zoom have enabled the seeing and showing of one another’s humanness. 

  4. Communicating Authentically During Times Of Crisis 4/19/2021

    John Fowler, cofounder and CEO of Kezar Life Sciences, shares “A Letter to Kezar Employees,” a best practice example of a leader communicating authentically and transparently during times of crisis (i.e., the killing of George Floyd).

  5. A Lesson Learned The Hard Way 4/18/2021

    Neil Kumar, cofounder and CEO of BridgeBio, discusses his rationale behind why employees didn’t have titles during the startup phase. 

  6. BridgeBio’s Neil Kumar Remembers Those Humble Beginnings 4/12/2021

    Neil Kumar, cofounder and CEO of BridgeBio, a company today valued at more than $10 billion, shares an embarrassing experience of the startup’s humble beginnings.

  7. Why John Fowler Is Not Your Typical Biopharma CEO 4/5/2021

    John Fowler’s atypical path to becoming a biopharmaceutical company cofounding CEO, began in Congress, along with a decade spent leading companies in completely different industries.

  8. How The CFO Role Has Evolved 3/22/2021

    Joseph Wolk, J.D., C.P.A, CFO of Johnson & Johnson (J&J), discusses how the CFO role has evolved from the days of monitoring debits and credits.

  9. A Behind The Scenes Look Into Enanta’s CEO, Jay Luly 2/22/2021

    From Big Pharma, to small biotech, to a VC, and then back to small biotech, Jay Luly, Ph.D., CEO of Enanta Pharmaceuticals, has seen his fair share of change in this ever-changing industry. 

  10. We Need To Expand How We Value Companies 1/25/2021

    During an interview for an upcoming feature in Life Science Leader, Sanjeev Redkar, Ph.D., cofounder and president of Apollomics (a biopharmaceutical company discovering and developing oncology treatments), discussed the topic of an exit strategy.